307 Results

People

  1. Old
    Old
  2. Ritter
    Ritter
  3. Allison
    Allison
  4. Rudensky
    Rudensky
  5. Gnjatic
    Gnjatic
  6. Wolchok
    Wolchok
  7. Jungbluth
    Jungbluth
  8. O'Reilly
    O'Reilly
  9. Pamer
    Pamer
  10. Yuan
    Yuan

Groups

  1. GSK Faculty (144)
  2. Department of Medicine (131)
  3. Sloan Kettering Institute Faculty (108)
  4. Sloan Kettering Institute Postdocs (90)
  5. Immunology Program Faculty (76)
  6. Hematologic Malignancies, Division of (67)
  7. Center for Hematologic Malignancies (64)
  8. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (60)
  9. Solid Tumor Oncology Division (58)
  10. Center for Molecular Imaging and Biotechnology (49)
  1. "cd4+ t lymphocyte"
Formats
  1. Journal Article (288)
  2. Review (10)
  3. Editorial (5)
  4. Research Letter (2)
  5. Conference Paper (1)
  6. Guidelines (1)
Groups
  1. GSK Faculty (144)
  2. Department of Medicine (131)
  3. Sloan Kettering Institute Faculty (108)
  4. Sloan Kettering Institute Postdocs (90)
  5. Immunology Program Faculty (76)
  6. Hematologic Malignancies, Division of (67)

More Groups

People
  1. Lloyd Old (31)
  2. Jedd Wolchok (26)
  3. Gerd Ritter (23)
  4. Alexander Rudensky (21)
  5. James Allison (21)
  6. Sacha Gnjatic (19)

More People

Years
  1. 2025 (12)
  2. 2024 (28)
  3. 2023 (12)
  4. 2022 (13)
  5. 2021 (10)
  6. 2020 (11)

More Years

Publications
  1. Blood (22)
  2. Journal of Immunology (21)
  3. Clinical Cancer Research (15)
  4. Journal of Experimental Medicine (13)
  5. Nature (11)
  6. PLoS ONE (11)

More Publications

Publishers
  1. Nature Publishing Group (40)
  2. American Society of Hematology (30)
  3. American Association for Cancer Research (27)
  4. Elsevier Inc. (22)
  5. The American Association of Immunologists, Inc (21)
  6. Cell Press (18)

More Publishers

Results (307)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Anti-CTLA-4 therapy results in higher CD4(+)ICOS(hi) T cell frequency and IFN-γ levels in both nonmalignant and malignant prostate tissues
    Journal Article

    Chen, H.; Liakou, C. I.; Kamat, A.; Pettaway, C.; Ward, J. F.; Tang, D. N.; Sun, J.; Jungbluth, A. A.; Troncoso, P.; Logothetis, C.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2009)

    Fulltext@MSK | Save
  • CD4(+) regulatory T cells control T(H)17 responses in a stat3-dependent manner
    Journal Article

    Chaudhry, A.; Rudra, D.; Treuting, P.; Samstein, R. M.; Liang, Y.; Kas, A.; Rudensky, A. Y.
    Science (2009)

    Fulltext@MSK | Save
  • Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire
    Journal Article

    Bioley, G.; Dousset, C.; Yeh, A.; Dupont, B.; Bhardwaj, N.; Mears, G.; Old, L. J.; Ayyoub, M.; Valmori, D.
    Clinical Cancer Research (2009)

    Fulltext@MSK | Save
  • CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit
    Journal Article

    Yuan, J.; Gnjatic, S.; Li, H.; Powel, S.; Gallardo, H. F.; Ritter, E.; Ku, G. Y.; Jungbluth, A. A.; Segal, N. H.; Rasalan, T. S.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2008)

    Fulltext@MSK | Save
  • Analysis of peripheral and local anti-tumor immune response in esophageal cancer patients after NY-ESO-1 protein vaccination
    Journal Article

    Wada, H.; Sato, E.; Uenaka, A.; Isobe, M.; Kawabata, R.; Nakamura, Y.; Iwae, S.; Yonezawa, K.; Yamasaki, M.; Miyata, H.; more...
    International Journal of Cancer (2008)

    Fulltext@MSK | Save
  • Induction of immune response against NY-ESO-1 by CHP-NY-ESO-1 vaccination and immune regulation in a melanoma patient
    Journal Article

    Tsuji, K.; Hamada, T.; Uenaka, A.; Wada, H.; Sato, E.; Isobe, M.; Asagoe, K.; Yamasaki, O.; Shiku, H.; Ritter, G.; more...
    Cancer Immunology, Immunotherapy (2008)

    Fulltext@MSK | Save
  • Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium Study 020
    Journal Article

    Spitzer, T. R.; Ambinder, R. F.; Lee, J. Y.; Kaplan, L. D.; Wachsman, W.; Straus, D. J.; Aboulafia, D. M.; Scadden, D. T.
    Biology of Blood and Marrow Transplantation (2008)

    Fulltext@MSK | Save
  • Phase II study of extended-dose temozolomide in patients with melanoma
    Journal Article

    Rietschel, P.; Wolchok, J. D.; Krown, S.; Gerst, S.; Jungbluth, A. A.; Busam, K.; Smith, K.; Orlow, I.; Panageas, K.; Chapman, P. B.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Response to pneumococcal (PNCRM7) and Haemophilus influenzae conjugate vaccines (HIB) in pediatric and adult recipients of an allogeneic hematopoietic cell transplantation (alloHCT)
    Journal Article

    Pao, M.; Papadopoulos, E. B.; Chou, J.; Heller, G.; Castro-Malaspina, H.; Jakubowski, A. A.; Kernan, N. A.; Perales, M. A.; Prokop, S.; Scaradavou, A.; more...
    Biology of Blood and Marrow Transplantation (2008)

    Fulltext@MSK | Save
  • Induction of regulatory T cell-resistant helper CD4+ T cells by bacterial vector
    Journal Article

    Nishikawa, H.; Tsuji, T.; Jager, E.; Briones, G.; Ritter, G.; Old, L. J.; Galán, J. E.; Shiku, H.; Gnjatic, S.
    Blood (2008)

    Fulltext@MSK | Save